About rizankizumab
Interleukin-23 inhibitor biologic
Used for
- Plaque psoriasis
- Psoriatic arthritis
- Crohn’s disease
- Ulcerative colitis
Usual adult dose
Psoriasis or psoriatic arthritis: 150 mg under the skin at weeks 0 and 4, then every 12 weeks. Bowel disease dosing differs and begins with intravenous infusions.
Common side effects
- Upper respiratory infections
- Injection-site reactions
- Headache
- Fatigue
Important warnings
- Do not start during an active serious infection.
- Screen for tuberculosis before treatment.
- Avoid live vaccines during treatment.
- Seek medical care for serious allergic reactions.
Pregnancy
Limited human data; discuss risks and benefits with a healthcare professional before use.
Breastfeeding
It is unknown whether risankizumab passes into breast milk; discuss with a healthcare professional.
Interactions
- Live vaccines may be unsafe during treatment.
- Other immune-suppressing medicines may increase infection risk.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.